Omega-3 fatty acids supplementation and oxidative stress parameters: A systematic review and meta-analysis of clinical trials.


Journal

Pharmacological research
ISSN: 1096-1186
Titre abrégé: Pharmacol Res
Pays: Netherlands
ID NLM: 8907422

Informations de publication

Date de publication:
11 2019
Historique:
received: 25 06 2019
revised: 25 08 2019
accepted: 20 09 2019
pubmed: 30 9 2019
medline: 25 6 2020
entrez: 30 9 2019
Statut: ppublish

Résumé

Omega-3 fatty acids (omega-3 FAs) supplementation effects on oxidants and antioxidants are always controversial. Oxidative stress (OS) is one of the major mechanisms that contribute to the pathogenesis of several chronic diseases. The present systematic review and meta-analysis aimed to summarize the finding of randomized clinical trials (RCTs) examining the effects of omega-3 FAs on OS markers. Five databases including PubMed, Embase, Scopus, Web of science, and Cochrane were searched up to May 5th, 2019 with no language restriction. RCTs included if they compared OS indices among subjects who received omega-3 FAs supplements and subjects who supplemented with placebo. To estimate the effects of omega-3 FAs supplementation, standardized mean difference (SMD) with 95% confidence intervals (95% CI) were pooled using random effects model. Of 5,887 publications, 39 trials involving 2,875 participants were included for the meta-analysis. The pooled analysis of data indicated that omega-3 FAs significantly increased serum total antioxidant capacity (TAC) (SMD: 0.48, 95% CI: 0.23, 0.72, P< 0.001; I

Identifiants

pubmed: 31563611
pii: S1043-6618(19)31191-0
doi: 10.1016/j.phrs.2019.104462
pii:
doi:

Substances chimiques

Fatty Acids, Omega-3 0
Reactive Oxygen Species 0
Malondialdehyde 4Y8F71G49Q
Glutathione Peroxidase EC 1.11.1.9

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104462

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Javad Heshmati (J)

Department of Nutritional Science, School of Nutritional Science and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Mojgan Morvaridzadeh (M)

Department of Nutritional Science, School of Nutritional Science and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Saman Maroufizadeh (S)

School of Nursing and Midwifery, Guilan University of Medical Sciences, Rasht, Iran.

Abolfazl Akbari (A)

Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran.

Mahsa Yavari (M)

Department of Nutritional Science, Texas Tech University, Lubbock, TX, USA.

Ali Amirinejad (A)

Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.

Arezoo Maleki-Hajiagha (A)

Research Development Center, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Mahdi Sepidarkish (M)

Department of Biostatistics and Epidemiology, Babol University of Medical Sciences, Babol, Iran. Electronic address: m.sepidarkish@mubabol.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH